Latest News by Industry
Century Therapeutics, Inc. [IPSC] has reported fiscal Q1 loss of $31.30 million.
On a per-share basis, the DE based company said its diluted earnings are $0.53.
The Biological Products, Except Diagnostic Substances firm posted revenue of $1.70 million in this period.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.